Lapatto, R., et al., “X-Ray Structure of Antistasin at 1.9 A Resolution and its Modelled Complex with Blood Coagulation Factor Xa”, EMBO J., 1997, vol. 16, No. 17, pp. 5151-5161. |
Mellott, M., et al., “Enhancement of Recombiant Tissue Plasminogen Activator-induced Reperfusion by Recombinant Tick Anticoagulant Peptide, A Selective Factor Xa Inhibitor, in a Canine Model of Femoral Arterial Thrombosis”, Fibinolysis, 1993, vol. 7, pp. 195-202. |
Lynch, J. Jr.,et al. “Primary Prevention of Coronary Arterial Thrombosis with the Factor Xa Inhibitor rTAP in a Canine Electrolytic Injury Model”, Thromb. Haemostasis, 1995, vol. 74, No. 2, pp. 640-645. |
Schaffer, L., et al., “Antithrombotic Efficacy of Recombinant Tick Anticoagulant Peptide”, Circulation, vol. 84, No. 4, 1991, pp. 1741-1748. |
Fioravanti, C., et al., “Antithrombotic Activity of Recombinant Tick Anticoagulant Peptide and Heparin in a Rabbit Model of Venous Thrombosis”, Thromb. Res., 1993, vol. 71, pp. 317-324. |
Wong, P., et al., “Antithrombotic Actions of Selective Inhibitors of Blood Coagulation Factor Xa in Rat Models of Thrombosis”, Thromb. Res., 1996, vol. 83, No. 2, pp. 117-126. |
Edmunds, J., et al., “Chapter 6. Thrombin and Factor Xa Inhibition”, Annual Reports of Medicinal Chemistry, 1996, pp. 51-60. |
Kunitada, S., et al., “Factor Xa Inhibitors”, Curr. Pharm. Des., 1996, vol. 2, pp. 531-542. |
Matuszczak, et al., “Syntheses in the Series of Pyrazoly-Substituted Quinoxalines”, Heterocycles, 1997, vol. 45, No. 12, pp. 2449-2462. |
Leardini, et al., “Peroxydicarbonate-Mediated Oxidation on N-(ortho-Aryloxyphenyl) and N-(ortho-Arylaminophenyl) aldimines”, 1995, Tetrahedron, vol. 51, No. 44, pp. 12143-12158. |
Otomasu, et al., “Synthesis of Condensed Quinoxalines III.1) 1,2-Dihydroimidazo[1,2-α]-quinoxalines and 1,2-Dihydro-3H-pryimido[1,2-α-]quinoxalines2)”, Chem. Pharm. Bull., 1970, vol. 90, No. 11, pp. 1391-1395. |
Seth, et al., “Studies in Antiamoebic Agents: Syntheses of Substituted Indophenazines, Azaindophenazines & Azaquinoxalines”, Indaian J. of Chem., 1974, vol. 12, pp. 124-128. |
Sparatore, et al., “Quinolizidine Derivatives as Potential Antitumoral Agents”, IL Farmaco, 1989, vol. 44, No. 10, pp. 945-950. |
Hahn F., et al., “Effect of Mepyramine and Spasmolytic Agents on Guinea-Pig Anaphylaxis with Special Reference to the Protracted Shock”, Arch. Int. Pharmacodyn., 1972, vol. 199, pp. 108-121. |
Chemical Abstract No. XP-002098893, 1989. |
Chemical Abstract No. XP-002098894, 1989. |
Chemical Abstract No. 116:83686, 1994. |
PCT International Search Report PCT/US98/26704, 1998. |
Katoh et al. Heterocycles 44(1) (1997) 357-366.* |
Kurasawa et al Chem. Pharm. Bull. 32(10) (1984) 4140-4143.* |
Morrow et al J. Org. Chem 36(1971) 27-31.* |
Ibrahim et al., Collect. Czech. Chem. Commun., vol. 55, No. 11, pp. 2715-2721 (1990). |